LeadIQ logo
Learn more at LeadIQ.com

Insights

Cutting-Edge Cancer Immunotherapy Verseau Therapeutics is revolutionizing cancer treatment with novel monoclonal antibody candidates designed to reprogram the tumor microenvironment and stimulate a robust anti-tumor immune response, presenting a significant sales opportunity for medical institutions seeking innovative oncology solutions.

Strategic Executive Appointments The recent appointments of industry veterans like John Edwards as CEO and Karen Tubridy signal a new era of growth and strategic direction for Verseau Therapeutics, providing an opportune moment for sales approaches to pharmaceutical companies looking to collaborate with experienced leadership in the biotechnology sector.

Investment Backing and Financial Stability With significant funding amounting to $50M and a revenue range of $0 - 10M, Verseau Therapeutics showcases financial stability and investor confidence, making it an attractive option for potential partnerships and sales engagements with investors seeking promising biotech ventures.

Key Stakeholder Network Verseau Therapeutics has built a robust network of investors including HealthCare Partners, 20/20 HealthCare Partners, Alexandria Venture Investments, and others, indicating strong industry support and opening doors for sales collaborations with companies associated with these prominent stakeholders.

Strategic Market Positioning In a competitive landscape with similar companies like Frontier Medicines, Kyverna Therapeutics, and Arrakis Therapeutics, Verseau stands out with its unique approach to cancer immunotherapy, presenting a prime sales opportunity for differentiation and market penetration to attract investors and potential clients.

Similar companies to Verseau Therapeutics

Verseau Therapeutics Tech Stack

Verseau Therapeutics uses 8 technology products and services including Google Analytics, Shopify, Font Awesome, and more. Explore Verseau Therapeutics's tech stack below.

  • Google Analytics
    Analytics
  • Shopify
    E-commerce
  • Font Awesome
    Font Scripts
  • jQuery
    Javascript Libraries
  • Open Graph
    Miscellaneous
  • Revslider
    Miscellaneous
  • RSS
    Miscellaneous
  • PHP
    Programming Languages

Media & News

Verseau Therapeutics's Email Address Formats

Verseau Therapeutics uses at least 1 format(s):
Verseau Therapeutics Email FormatsExamplePercentage
First.Last@verseautx.comJohn.Doe@verseautx.com
50%
First.Last@verseautx.comJohn.Doe@verseautx.com
50%

Frequently Asked Questions

Where is Verseau Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Verseau Therapeutics's main headquarters is located at 47 Wiggins Ave Bedford, Massachusetts 01730 US. The company has employees across 1 continents, including North America.

What is Verseau Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Verseau Therapeutics's official website is verseautx.com and has social profiles on LinkedIn.

How much revenue does Verseau Therapeutics generate?

Minus sign iconPlus sign icon
As of September 2024, Verseau Therapeutics's annual revenue reached $1.8M.

What is Verseau Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Verseau Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Verseau Therapeutics have currently?

Minus sign iconPlus sign icon
As of September 2024, Verseau Therapeutics has approximately 11 employees across 1 continents, including North America. Key team members include Director Computational Biology: Z. Z.Office Manager: A. R.Office Manager And Executive Administrator: A. R.. Explore Verseau Therapeutics's employee directory with LeadIQ.

What industry does Verseau Therapeutics belong to?

Minus sign iconPlus sign icon
Verseau Therapeutics operates in the Biotechnology Research industry.

What technology does Verseau Therapeutics use?

Minus sign iconPlus sign icon
Verseau Therapeutics's tech stack includes Google AnalyticsShopifyFont AwesomejQueryOpen GraphRevsliderRSSPHP.

What is Verseau Therapeutics's email format?

Minus sign iconPlus sign icon
Verseau Therapeutics's email format typically follows the pattern of . Find more Verseau Therapeutics email formats with LeadIQ.

How much funding has Verseau Therapeutics raised to date?

Minus sign iconPlus sign icon
As of September 2024, Verseau Therapeutics has raised $50M in funding. The last funding round occurred on Oct 21, 2019 for $50M.

When was Verseau Therapeutics founded?

Minus sign iconPlus sign icon
Verseau Therapeutics was founded in 2017.
Verseau Therapeutics

Verseau Therapeutics

Biotechnology ResearchMassachusetts, United States11-50 Employees

Verseau is focused on developing the next major wave of cancer immunotherapies directed at a broad and potent reprogramming of the tumor microenvironment to attack tumors. This is accomplished by stimulating macrophages to shift their phenotype from immunosuppressive to a pro-inflammatory, anti-tumor state in a process called macrophage repolarization.  Verseau developed a unique target discovery engine that leveraged patient data and computational biology to discover and validate over 20 novel macrophage targets. Verseau’s first-in-class monoclonal antibody candidates, VTX-0811 targeting PSGL-1 and VTX-1218 targeting VSIG4, are in late preclinical development and progressing toward clinical trials. 

Section iconCompany Overview

Headquarters
47 Wiggins Ave Bedford, Massachusetts 01730 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
11-50

Section iconFunding & Financials

  • $50M

    Verseau Therapeutics has raised a total of $50M of funding over 2 rounds. Their latest funding round was raised on Oct 21, 2019 in the amount of $50M.

  • $10M

    Verseau Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $50M

    Verseau Therapeutics has raised a total of $50M of funding over 2 rounds. Their latest funding round was raised on Oct 21, 2019 in the amount of $50M.

  • $10M

    Verseau Therapeutics's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.